Cross-Sector entity
Phil Weiser is most often covered alongside AmerisourceBergen, which appears in 2 of these 4 stories. That works out to roughly 1.3 stories per week across a 21-day span. The busiest single day carried 2. funding accounts for 2 of the 4 tracked stories, while 2 other categories carry the remainder.
4 verified stories tracked
Last mentioned: Aug 2, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Phil Weiser is most often covered alongside AmerisourceBergen, which appears in 2 of these 4 stories. That works out to roughly 1.3 stories per week across a 21-day span. The busiest single day carried 2. funding accounts for 2 of the 4 tracked stories, while 2 other categories carry the remainder. Each carries 2.5 original sources on average. Phil Weiser appears in 4 tracked Cross-Sector stories published from July 13, 2026 through August 2, 2026.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Phil Weiser. Shared-story counts are live from our verified record — not editorial picks.
Colorado’s $12M opioid grant round, awarded to 27 organizations, will bolster youth treatment, prison re-entry support, and a rural behavioral health workforce—key gaps in the state’s healthcare delivery system. The highly competitive process drew 287 applications, highlighting the severe need for prevention infrastructure.
Colorado’s distribution of $12 million to 27 groups from opioid settlement funds is the latest reminder of pharma’s enduring financial and reputational liabilities. The grants, part of a broader $700M+ state settlement, fuel prevention programs while underscoring that litigation costs continue to ripple through the industry.
Source: kjct8.com
The lawsuit by 12 states to block Paramount's $81B acquisition of Warner Bros. Discovery could reshape the advertising and content distribution landscape, affecting ad inventory consolidation, streaming competition, and brand safety dynamics around combined news assets like CNN. With the merger's fate uncertain, marketers and media buyers face potential disruptions in upfront negotiations, content exclusivity deals, and addressable TV targeting.
A coalition of 12 states filed a federal antitrust suit to halt Paramount's $81B acquisition of Warner Bros. Discovery, alleging the deal violates the Clayton Act by reducing competition in film and TV. The litigation directly challenges the Trump DOJ’s approval, setting up a state-federal enforcement battle with major implications for media consolidation precedent. The companies vow to fight, while the court will weigh the merger's impact on consumers, theaters, and content diversity.
Source: journal-advocate.com · bnnbloomberg.ca
